A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The primary objective of this study is to evaluate the efficacy of AVTX-002 compared with placebo in patients with poorly controlled non-eosinophilic asthma (NEA).
Epistemonikos ID: b61cc62fba5c2fefb5be1e83651c06d86a523563
First added on: May 10, 2024